Elucidating the immunomodulatory role of endocannabinoids in intervertebral disc degeneration

被引:0
|
作者
Vasudevan, Gowdaman [2 ]
Ramachandran, Karthik [1 ]
Tangavel, Chitraa [2 ]
Nayagam, Sharon Miracle [2 ]
Gopalakrishnan, Chellappa [2 ]
Muthurajan, Raveendran [3 ]
Anand, K. S. Sri Vijay [1 ]
Rajasekaran, Shanmuganathan [1 ]
机构
[1] Ganga Hosp, Dept Spine Surg, 313 Mettupalayam Rd, Coimbatore, India
[2] Ganga Res Ctr, SF 442,NGGO Colony Post, Coimbatore 641022, Tamil Nadu, India
[3] Tamil Nadu Agr Univ, Dept Plant Biotechnol, Lawley Rd, Coimbatore, India
关键词
Metagenome; Metabolome; Signalling lipids; Endocannabinoids; 2-Arachidonylglycerol; N-arachidonoylethanolamine; PROSTAGLANDINS; CANNABINOIDS; VIRULENCE; BINDING;
D O I
10.1007/s00586-024-08550-w
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PurposeThe endocannabinoid system (ECS) has been well-established to play a crucial role in the regulation of several physiological processes as well as many inflammatory disease conditions. However, its role in intervertebral disc degeneration has been least explored. We aim to investigate the immunomodulatory role of endocannabinoids in regulating IVD health.MethodsThe study population included 20 healthy volunteers (controls) and 40 patients with disc degeneration (disease group) (20 Modic and 20 Non Modic). 16S metagenome sequencing of the V3-V4 region was performed for the DNA extracted from NP tissue samples of both control and disease groups. Sequencing was carried out using the Novaseq 6000 platform using 250 bp paired-end chemistry. A global metabolic profile was obtained using the uHPLC system coupled with Q Exactive Plus Hybrid Quadrupole-Orbitrap mass spectrometer.ResultsOur study revealed a higher prevalence of gram-negative bacteria, particularly opportunistic pathogens like Pseudomonas, in diseased discs (71-81%) compared to healthy controls (54%). Further investigation using metabolomics identified significant changes in the lipid profiles of diseased discs. We found that the signalling molecules of the ECS, 2-arachidonylglycerol (2-AG) and N-arachidonoylethanolamine (AEA), were significantly lower in diseased discs compared to controls (Log2FC -2.62 for 2-AG and -3.15 for AEA). Conversely, pro-inflammatory metabolites like LTA4, HPETE, HETE, and Prostaglandin G2 were elevated in diseased discs, with a Log2 fold increase greater than 2.5.ConclusionThe study reveals that the endocannabinoid metabolites (2-AG and AEA) of the ECS could be a significant molecule influencing susceptibility to infection and inflammation within the intervertebral discs, which could be a potential target for improving disc health.Level of evidenceDiagnostic: individual cross-sectional studies with consistently applied reference standard and blinding.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 50 条
  • [21] Role of mitophagy in intervertebral disc degeneration: A narrative review
    Wu, Zuo-long
    Liu, Yong
    Song, Wei
    Zhou, Kai-sheng
    Ling, Yan
    Zhang, Hai-hong
    OSTEOARTHRITIS AND CARTILAGE, 2025, 33 (01) : 27 - 41
  • [22] The Potential Role of Cytokines in Diabetic Intervertebral Disc Degeneration
    Li, Sunlong
    Huang, Chongan
    Xiao, Jian
    Wu, Yuhao
    Zhang, Zengjie
    Zhou, Yifei
    Tian, Naifeng
    Wu, Yaosen
    Wang, Xiangyang
    Zhang, Xiaolei
    AGING AND DISEASE, 2022, 13 (05): : 1323 - 1335
  • [23] The Role of Type I Diabetes in Intervertebral Disc Degeneration
    Russo, Fabrizio
    Ambrosio, Luca
    Ngo, Kevin
    Vadala, Gianluca
    Denaro, Vincenzo
    Fan, Yong
    Sowa, Gwendolyn
    Kang, James D.
    Vo, Nam
    SPINE, 2019, 44 (17) : 1177 - 1185
  • [24] The role of ageing and oxidative stress in intervertebral disc degeneration
    Wen, Pengfei
    Zheng, Bolong
    Zhang, Binfei
    Ma, Tao
    Hao, Linjie
    Zhang, Yumin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [25] ROLE OF CYTOKINES AND CHEMOKINES IN HUMAN INTERVERTEBRAL DISC DEGENERATION
    Phillips, Kate L. E.
    Cross, Alison
    Chiverton, Neil
    Haddock, Gail
    Bunning, Rowena A. D.
    Le Maitre, Christine L.
    RHEUMATOLOGY, 2012, 51 : 147 - 147
  • [26] Intervertebral disc degeneration in the dog. Part 1: Anatomy and physiology of the intervertebral disc and characteristics of intervertebral disc degeneration
    Bergknut, Niklas
    Smolders, Lucas A.
    Grinwis, Guy C. M.
    Hagman, Ragnvi
    Lagerstedt, Anne-Sofie
    Hazewinkel, Herman A. W.
    Tryfonidou, Marianna A.
    Meij, Bjorn P.
    VETERINARY JOURNAL, 2013, 195 (03): : 282 - 291
  • [27] Treatment of Intervertebral Disc Degeneration
    Xin, Jingguo
    Wang, Yongjie
    Zheng, Zhi
    Wang, Shuo
    Na, Shibo
    Zhang, Shaokun
    ORTHOPAEDIC SURGERY, 2022, 14 (07) : 1271 - 1280
  • [28] Genetics of Intervertebral Disc Degeneration
    Ou-Yang, David C.
    Kleck, Christopher J.
    Ackert-Bicknell, Cheryl L.
    CURRENT OSTEOPOROSIS REPORTS, 2023, 21 (01) : 56 - 64
  • [29] Fundamentals of Intervertebral Disc Degeneration
    Kirnaz, Sertac
    Capadona, Charisse
    Wong, Taylor
    Goldberg, Jacob L.
    Medary, Branden
    Sommer, Fabian
    McGrath, Lynn B., Jr.
    Hartl, Roger
    WORLD NEUROSURGERY, 2022, 157 : 264 - 273
  • [30] MicroRNA in intervertebral disc degeneration
    Li, Zheng
    Yu, Xin
    Shen, Jianxiong
    Chan, Matthew T. V.
    Wu, William Ka Kei
    CELL PROLIFERATION, 2015, 48 (03) : 278 - 283